Copyright
©The Author(s) 2020.
World J Orthop. Feb 18, 2020; 11(2): 90-106
Published online Feb 18, 2020. doi: 10.5312/wjo.v11.i2.90
Published online Feb 18, 2020. doi: 10.5312/wjo.v11.i2.90
Table 1 Incidence for postoperative delirium in specific orthopedic procedures from 2009 to 2014
Procedure | Incidence (%) |
Primary THA | 0.8 |
Bilateral THA | 0.4 |
Primary TKA | 1.2 |
Bilateral TKA | 1.2 |
Spine fusion | 3.3 |
Other spine procedures | 1.9 |
Femur/pelvic fracture | 7.2 |
Other procedures | 1.0 |
Table 2 Patient demographics and study population
POD (Mean +/- SD or n, %), n = 959 | Non-POD (Mean +/- SD or n, %), n = 77533 | P value | |
Age, yr | 72.7+/-12.9 | 62.3+/-14.1 | < 0.001a |
≥ 70 | 610 (63.6) | 24038 (31.0) | < 0.001a |
Male | 389 (40.6) | 34777 (44.9) | 0.008a |
BMI | 28.2+/-6.2 | 28.0+/-6.1 | 0.003a |
Procedure type | < 0.001a | ||
THA | 161 (16.8) | 19753 (25.5) | |
TKA | 249 (26.0) | 20106 (25.9) | |
Bilateral THA | 3 (0.3) | 853 (1.1) | |
Bilateral TKA | 29 (3.0) | 2337 (3.0) | |
Spine fusions | 140 (14.6) | 4135 (5.3) | |
Other spine procedures | 126 (13.1) | 6587 (8.5) | |
Other procedures | 251 (26.2) | 23762 (30.7) | |
Trauma | < 0.001a | ||
Fracture of femur/pelvis | 57 (5.9) | 731 (0.9) | |
Other trauma | 30 (3.1) | 2607 (3.4) | |
No trauma | 872 (90.9) | 74195 (95.7) | |
Length of stay | 6.0+/-7.5 | 3.0+/-3.2 | < 0.001a |
Latest creatinine before surgery | < 0.001a | ||
< 1.2 mg/dL | 825 (86.0) | 71048 (91.6) | |
1.2-2.0 mg/dL | 123 (12.8) | 6229 (8.0) | |
> 2.0 mg/d | 11 (1.2) | 256 (0.3) | |
Preoperative hyponatremia | < 0.001a | ||
Yes | 367 (38.3) | 21290 (27.5) | |
No | 591 (61.6) | 56190 (72.5) | |
Missing | 1 (0.1) | 53 (0.07) | |
Postoperative thiamine order | < 0.001a | ||
Yes | 119 (12.4) | 1390 (1.8) | |
No | 839 (87.5) | 76122 (98.2) | |
Missing | 1 (0.1) | 21 (0.03) | |
Atrial fibrillation (present on admission) | 130 (13.6) | 3815 (4.9) | < 0.001a |
Pressure ulcers (present on admission) | 23 (2.4) | 323 (0.42) | < 0.001a |
Opioid dependence or long-term use | 29 (6.2) | 1245 (1.6) | < 0.001a |
Psychiatric disease (present on admission) | 356 (37.1) | 16716 (21.6) | < 0.001a |
Anesthesia type | < 0.001a | ||
General | 344 (35.9) | 16356 (21.9) | |
Other | 578 (60.3) | 56067 (72.3) | |
Missing | 37 (3.9) | 4510 (5.8) | |
Patient-controlled analgesia | < 0.001a | ||
Epidural | 413 (43.1) | 40991 (52.9) | |
IV | 441 (46.0) | 22458 (29.0) | |
Peripheral nerve infusion | 11 (1.2) | 949 (1.2) | |
Missing | 94 (9.8) | 13135 (16.9) | |
Received diazepam | < 0.001a | ||
Yes | 98 (10.2) | 3135 (4.0) | |
No | 860 (89.7) | 74377 (95.9) | |
Missing | 1 (0.1) | 21 (0.03) | |
CT, MRI or both performed | < 0.001a | ||
Yes | 872 (90.9) | 64838 (83.6) | |
No | 86 (9.0) | 12674 (16.4) | |
Missing | 1 (0.1) | 21 (0.03) | |
ASA score | < 0.001a | ||
1 | 7 (0.73) | 4933 (6.4) | |
2 | 477 (49.7) | 53801 (69.4) | |
≥ 3 | 438 (45.7) | 14274 (18.4) | |
Missing | 37 (3.9) | 4525 (5.8) |
Table 3 Total hip arthroplasty patient demographics and study population1
POD (Mean +/- SD or n, %), n = 140 | Non-POD (Mean +/- SD or n, %), n = 18232 | P value | |
Age, yr | 77.6+/-10.4 | 65.5+/-11.4 | < 0.001a |
≥ 70 | 112 (80.0) | 6499 (35.65) | < 0.001a |
Male | 57 (40.7) | 7891 (43.28) | 0.54 |
BMI | 26.7+/-5.2 | 28.4+/-5.8 | < 0.001a |
Length of stay | 6.1+/-4.0 | 3.3+/-1.5 | < 0.001a |
Latest creatinine before surgery | < 0.001a | ||
< 1.2 mg/dL | 107 (76.4) | 16376 (89.8) | |
1.2-2.0 mg/dL | 29 (20.7) | 1781 (9.8) | |
> 2.0 mg/dL | 4 (2.9) | 75 (0.4) | |
Preoperative hyponatremia | < 0.001a | ||
Yes | 40 (28.6) | 2525 (13.9) | |
No | 100 (71.4) | 15700 (86.1) | |
Missing | 0 (0) | 7 (0.04) | |
Postoperative thiamine order | < 0.001a | ||
Yes | 17 (12.1) | 387 (2.1) | |
No | 123 (87.9) | 17844 (97.9) | |
Missing | 0 (0) | 1 (0.01) | |
Atrial fibrillation (present on admission) | 5 (3.6) | 119 (0.7) | < 0.001a |
Pressure ulcers (present on admission) | 1 (0.7) | 47 (0.3) | 0.31 |
Opioid dependence or long-term use | 9 (6.4) | 199 (1.1) | < 0.001a |
Psychiatric disease (present on admission) | 47 (33.6) | 3584 (19.7) | < 0.001a |
Anesthesia type | 0.55 | ||
General | 4 (2.7) | 384 (2.1) | |
Other | 136 (97.1) | 17805 (97.7) | |
Missing | 0 (0) | 40 (0.2) | |
Patient-controlled analgesia | < 0.001a | ||
Epidural | 102 (72.9) | 14235 (78.1) | |
IV | 24 (17.1) | 1306 (7.2) | |
Missing | 14 (10) | 2691 (14.8) | |
Received diazepam | 0.03a | ||
Yes | 8 (5.7) | 453 (2.5) | |
No | 132 (94.3) | 17778 (97.5) | |
Missing | 0 (0) | 1 (0.01) | |
CT, MRI or both performed | 0.009a | ||
Yes | 127 (90.7) | 15616 (85.7) | |
No | 13 (9.3) | 2615 (14.3) | |
Missing | 0 (0) | 1 (0.01) | |
ASA score | < 0.001a | ||
2 | 73 (52.1) | 14667 (80.5) | |
≥ 3 | 67 (47.9) | 3519 (19.3) | |
Missing | 0 (0) | 46 (0.25) |
Table 4 Total knee arthroplasty patient demographics and study population
POD (Mean +/- SD or n, %), n = 245 | non-POD (Mean +/- SD or n, %), n = 19864 | P value | |
Age, yr | 75.1+/-9.3 | 67.6+/-10 | < 0.001a |
≥ 70 | 171 (69.8) | 8304 (41.8) | < 0.001a |
Male | 89 (36.3) | 7364 (37.1) | 0.81 |
BMI | 30.0+/-6.1 | 30.6+/-6.3 | 0.13 |
Length of stay | 6.0+/-3.2 | 3.8+/-1.5 | < 0.001a |
Latest creatinine before surgery | < 0.001a | ||
< 1.2 mg/dL | 203 (82.9) | 17828 (89.8) | |
1.2-2.0 mg/dL | 37 (15.1) | 1954 (9.8) | |
> 2.0 mg/dL | 5 (2.0) | 82 (0.4) | |
Preoperative hyponatremia | 0.07 | ||
Yes | 45 (18.4) | 2837 (14.3) | |
No | 200 (81.6) | 17019 (85.7) | |
Missing | 0 (0) | 8 (0.04) | |
Postoperative thiamine order | < 0.001a | ||
Yes | 28 (11.4) | 332 (1.7) | |
No | 217 (88.6) | 19530 (98.3) | |
Missing | 0 (0) | 2 (0.01) | |
Atrial fibrillation (present on admission) | 46 (18.8) | 1190 (6.0) | < 0.001a |
Pressure ulcers (present on admission) | 1 (0.4) | 29 (0.2) | 0.31 |
Opioid dependence or long-term use | 9 (3.7) | 198 (1.0) | 0.001a |
Psychiatric disease (present on admission) | 77 (31.4) | 3915 (19.7) | < 0.001a |
Anesthesia type | 0.04a | ||
General | 12 (4.9) | 545 (2.7) | |
Other | 233 (95.1) | 19252 (96.9) | |
Missing | 0 (0) | 67 (0.3) | |
Patient-controlled analgesia | 0.005a | ||
Epidural | 179 (73.1) | 15151 (76.3) | |
IV | 38 (15.5) | 1801 (9.1) | |
Peripheral nerve infusion | 9 (3.7) | 711 (3.6) | |
Missing | 19 (7.8) | 2201 (11.1) | |
Received diazepam | 0.003a | ||
Yes | 12 (4.9) | 381 (1.9) | |
No | 233 (95.1) | 19481 (98.1) | |
Missing | 0 (0) | 2 (0.01) | |
CT, MRI or both performed | 0.14 | ||
Yes | 226 (92.2) | 17733 (89.3) | |
No | 19 (7.8) | 2129 (10.7) | |
Missing | 0 (0) | 2 (0.01) | |
ASA score | < 0.001a | ||
1 | 2 (0.8) | 489 (2.46) | |
2 | 130 (53.1) | 14933 (75.2) | |
≥ 3 | 113 (46.1) | 4327 (22.0) | |
Missing | 0 (0) | 70 (0.4) |
Table 5 Spine fusion patient demographics and study population
POD (Mean +/- SD or n, %), n = 137 | non-POD (Mean +/- SD or n, %), n = 4107 | P value | |
Age, yr | 67.5+/-12.5 | 60.1+/-15.6 | < 0.001a |
≥ 65 | 91 (66.4) | 1765 (43.0) | < 0.001a |
Male | 54 (39.4) | 1810 (44.1) | 0.28 |
BMI | 28.5+/-6.5 | 28.1+/-5.9 | 0.40 |
Length of stay | 9.0+/-5.1 | 5.6+/-3.6 | < 0.001a |
Latest creatinine before surgery | 0.01a | ||
< 1.2 mg/dL | 116 (84.7) | 3754 (91.4) | |
1.2-2.0 mg/dL | 20 (14.6) | 346 (8.4) | |
> 2.0 mg/dL | 1 (0.7) | 7 (0.2) | |
Preoperative hyponatremia | 0.16 | ||
Yes | 43 (31.4) | 1070 (26.1) | |
No | 94 (68.6) | 3033 (73.9) | |
Missing | 0 (0) | 4 (0.1) | |
Postoperative thiamine order | < 0.001a | ||
Yes | 20 (14.6) | 93 (2.3) | |
No | 117 (85.4) | 4013 (97.7) | |
Missing | 0 (0) | 1 (0.02) | |
Atrial fibrillation (present on admission) | 12 (8.8) | 135 (3.3) | 0.003a |
Pressure ulcers (present on admission) | 3 (2.2) | 13 (0.32) | < 0.001a |
Opioid dependence or long-term use | 11 (8.0) | 124 (3.0) | 0.004a |
Psychiatric disease (present on admission) | 65 (47.5) | 1185 (28.9) | < 0.001a |
Anesthesia type | 1 | ||
General | 136 (99.3) | 4052 (98.7) | |
Other | 0 (0) | 8 (0.2) | |
Missing | 1 (0.7) | 47 (1.1) | |
Patient-controlled analgesia | 1 | ||
Epidural | 0 (0) | 18 (0.4) | |
IV | 136 (99.3) | 3968 (96.6) | |
Missing | 1 (0.7) | 121 (3.0) | |
Received diazepam | < 0.001a | ||
Yes | 34 (24.8) | 476 (11.6) | |
No | 103 (75.2) | 3630 (88.4) | |
Missing | 0 (0) | 1 (0.02) | |
CT, MRI or both performed | 0.26 | ||
Yes | 136 (99.3) | 3999 (97.4) | |
No | 1 (0.7) | 107 (2.6) | |
Missing | 0 (0) | 1 (0.02) | |
ASA score | < 0.001a | ||
1 | 1 (0.7) | 214 (5.2) | |
2 | 78 (56.9) | 2974 (72.4) | |
≥ 3 | 57 (41.6) | 871 (21.2) | |
Missing | 1 (0.7) | 48 (1.2) |
Table 6 Perioperative risk factors and adjusted association with postoperative delirium by procedure
THAOR (95%CI), n = 18276 | THA P value | TKAOR (95%CI), n = 19987 | TKA P value | SFOR (95%CI), n = 4183 | SF P value | |
Age, yr | ||||||
≥ 70 vs < 70 | 4.9 (3.0, 7.9) | < 0.001a | 2.16 (1.58, 2.94) | < 0.001a | - | - |
≥ 65 vs < 65 | - | - | - | - | 2.76 (1.79, 4.25) | < 0.001a |
Male | 0.90 (0.60, 1.35) | 0.62 | 0.82 (0.60, 1.12) | 0.21 | 0.73 (0.48, 1.10) | 0.13 |
BMI | 0.94 (0.90, 0.98) | 0.004a | 0.99 (0.96, 1.02) | 0.37 | 0.99 (0.95, 1.02) | 0.46 |
Latest creatinine value before surgery | ||||||
1.2-2.0 mg/dL vs < 1.2 mg/dL | 1.77 (1.05, 3.00) | 0.03a | 0.79 (0.49, 1.27) | 0.32 | 1.40 (0.73, 2.68) | 0.31 |
> 2.0 mg/dL vs < 1.2 mg/dL | 4.08 (1.06, 15.66) | 0.04a | 1.39 (0.46, 4.20) | 0.56 | 2.26 (0.20, 26.24) | 0.51 |
Preoperative hyponatremia | 2.36 (1.54, 3.64) | < 0.001a | 1.25 (0.87, 1.79) | 0.23 | 1.24 (0.82, 1.88) | 0.31 |
PCA route | ||||||
IV vs Epidural | 1.98 (1.19, 3.28) | 0.008a | 1.26 (0.83, 1.92) | 0.27 | - | - |
Peripheral nerve infusion vs Epidural | - | - | 0.93 (0.47, 1.86) | 0.85 | - | - |
Postoperative thiamine order | 5.05 (2.72, 9.37) | < 0.001a | 6.40 (4.00, 10.26) | <0.001a | 6.64 (3.72, 11.85) | <0.001a |
ASA Score | ||||||
2 vs 1 | - | - | 1.91 (0.26, 13.88) | 0.52 | 1.90 (0.25, 14.19) | 0.53 |
> 3 vs 1 | - | - | 3.63 (0.49, 26.74) | 0.21 | 2.38 (0.31, 18.46) | 0.41 |
≥ 3 vs 2 | 2.01 (1.33, 3.05) | < 0.001a | - | - | - | - |
Anesthesia type | ||||||
Other vs general | 2.92 (0.66, 12.85) | 0.16 | 0.89 (0.43, 1.82) | 0.74 | - | - |
Surgery length | 1.00 (1.00, 1.01) | 0.10 | 1.00 (0.99, 1.01) | 0.55 | 1.00 (1.00, 1.00) | <0.001a |
Atrial fibrillation, present on admission | 0.97 (0.53, 1.77) | 0.91 | 1.93 (1.32, 2.81) | <0.001a | 2.19 (1.09, 4.41) | 0.03a |
Pressure ulcers, present on admission | 0.65 (0.08, 5.05) | 0.68 | - | - | 7.56 (1.89, 30.24) | 0.004a |
Opioid dependence or long-term use | 7.11 (3.26, 15.51) | < 0.001a | 2.98 (1.38, 6.41) | 0.005a | 1.88 (0.91, 3.90) | 0.09 |
Parenteral diazepam | 5.05 (1.5, 16.97) | 0.009a | 4.40 (1.52, 12.75) | 0.007a | 2.17 (1.19, 3.97) | 0.01a |
Elixhauser comorbidity | ||||||
Deficiency anemias | 1.64 (0.74, 3.63) | 0.22 | 1.10 (0.57, 2.11) | 0.78 | 1.11 (0.42, 2.93) | 0.83 |
Congestive heart failure | 2.35 (0.93, 5.96) | 0.07 | 1.59 (0.74, 3.38) | 0.23 | 1.54 (0.39, 6.11) | 0.54 |
Rheumatoid arthritis/collagen vascular diseases | 1.06 (0.45, 2.51) | 0.900 | 0.35 (0.13, 0.94) | 0.04a | 1.02 (0.49, 2.13) | 0.95 |
Chronic pulmonary disease | 1.13 (0.67, 1.92) | 0.64 | 0.84 (0.55, 1.28) | 0.41 | 1.06 (0.65, 1.73) | 0.82 |
Coagulopathy | 1.32 (0.39, 4.53) | 0.66 | 1.60 (0.70, 3.62) | 0.26 | 2.80 (1.05, 7.50) | 0.04a |
Depression | 1.70 (1.05, 2.75) | 0.03a | 1.47 (1.02, 2.11) | 0.04a | 2.61 (1.73, 3.92) | <0.001a |
Diabetes w/o chronic complications | 1.54 (0.90, 2.64) | 0.12 | 1.90 (1.36, 2.66) | < 0.001a | 1.54 (0.92, 2.58) | 0.10 |
Diabetes w chronic complications | 2.05 (0.45, 9.23) | 0.35 | 1.77 (0.68, 4.58) | 0.24 | 3.34 (1.02, 10.91) | 0.046a |
Hypertension | 1.62 (1.06, 2.48) | 0.03a | 1.21 (0.59, 1.64) | 0.23 | 1.00 (0.66, 1.51) | 0.99 |
Hypothyroidism | 1.01 (0.61, 1.66) | 0.98 | 1.46 (1.06, 2.02) | 0.02a | 1.07 (0.65, 1.76) | 0.80 |
Liver disease | 0.41 (0.05, 3.22) | 0.40 | 0.70 (0.16, 3.07) | 0.63 | 0.71 (0.15, 3.30) | 0.66 |
Lymphoma | 1.33 (0.25, 7.20) | 0.74 | - | - | - | - |
Fluid and electrolyte disorders | 0.31 (0.04, 2.43) | 0.26 | 1.41 (0.44, 4.56) | 0.57 | 1.14 (0.36, 3.63) | 0.82 |
Other neurological disorders | 2.04 (0.98. 4.27) | 0.06 | 2.79 (1.69, 4.60) | < 0.001a | 2.14 (1.10, 4.14) | 0.02a |
Obesity | 1.06 (0.53, 2.12) | 0.88 | 0.79 (0.53, 1.19) | 0.27 | 1.56 (0.90, 2.69) | 0.11 |
Peripheral vascular disorders | 1.20 (0.47, 3.10) | 0.70 | 1.40 (0.62, 3.16) | 0.42 | 1.68 (0.64, 4.42) | 0.30 |
Psychoses | 2.52 (0.81, 7.90) | 0.11 | 6.39 (3.51, 11.62) | < 0.001a | 4.95 (2.38, 10.28) | <0.001a |
Pulmonary circulation disorders | 1.20 (0.47, 3.10) | 0.70 | 1.69 (0.89, 3.23) | 0.11 | 1.57 (0.51, 4.88) | 0.44 |
Renal failure | 0.94 (0.41, 2.15) | 0.88 | 2.32 (1.31, 4.11) | 0.004a | 0.97 (0.39, 2.45) | 0.95 |
Solid tumor w/o metastasis | - | - | 1.42 (0.31, 6.45) | 0.65 | - | - |
Valvular disease | 1.08 (0.59, 1.97) | 0.80 | 1.23 (0.79, 1.92) | 0.37 | 1.17 (0.61, 2.26) | 0.63 |
Weight loss | 0.61 (0.05, 7.46) | 0.70 | 7.14 (0.62, 82.11) | 0.11 | - | - |
- Citation: Urban MK, Sasaki M, Schmucker AM, Magid SK. Postoperative delirium after major orthopedic surgery. World J Orthop 2020; 11(2): 90-106
- URL: https://www.wjgnet.com/2218-5836/full/v11/i2/90.htm
- DOI: https://dx.doi.org/10.5312/wjo.v11.i2.90